Top compounds associated with response to FLJ22763


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.3
mRNA SRT-1720 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.042 0.3
mRNA prima-1 CTRPv2 pan-cancer AAC -0.034 0.3
mRNA istradefylline CTRPv2 pan-cancer AAC -0.064 0.3
mRNA tigecycline CTRPv2 pan-cancer AAC -0.053 0.3
mRNA Teniposide CTRPv2 pan-cancer AAC -0.042 0.3
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.036 0.3
Download CSV